Bulletin
Investor Alert

Bristol-Myers Squibb Co.

NYS: BMY

GO
/marketstate/country/us

After Hours

BMY
/zigman2/quotes/202559280/composite

$

60.42

Change

+0.02 +0.03%

Volume

Volume 3.40m

May 27, 2020, 7:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202559280/composite

Previous close

$ 60.32

$ 60.40

Change

+0.08 +0.13%

Day low

Day high

$59.11

$60.52

Open
Open: 60.00

52 week low

52 week high

$42.48

$68.34

Open

Market cap

$136.49B

Average volume

16.84M

P/E ratio

74.66

Rev. per Employee

$968,283

EPS

0.81

Dividend

0.41

Div yield

2.98%

Ex dividend date

7/3/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bmy

MarketWatch News on BMY

  1. 15 Cheap Stocks Growing Fast Enough to Avoid Value Trap

    10:10 a.m. May 26, 2020

    - Nicholas Jasinski

  2. Amazon is Now a Low-Volatility Stock

    9:46 a.m. May 24, 2020

    - Evie Liu

  3. The Nasdaq Is Positive for the Year Despite Grim News on Jobs

    4:41 p.m. May 7, 2020

    - Barbara Kollmeyer

  4. Bristol-Myers Climbs After Strong Earnings, Upbeat Forecast

    10:12 a.m. May 7, 2020

    - Josh Nathan-Kazis

  5. Bristol Myers shares jump 2.2% premarket

    7:08 a.m. May 7, 2020

    - Ciara Linnane

  6. Bristol Myers still sees 2020 adj. EPS $6.00 to $6.20

    7:08 a.m. May 7, 2020

    - Ciara Linnane

  7. Bristol Myers still sees 2020 revenue $40.0 bln to $42.0 bln

    7:07 a.m. May 7, 2020

    - Ciara Linnane

  8. Bristol Myers now sees 2020 EPS of 37 cents to 57 cents vs. prior 75 cents to 95 cents

    7:07 a.m. May 7, 2020

    - Ciara Linnane

  9. Bristol Myers Q1 revenue $10.781 bln vs. $5.920 bln; FactSet consensus $10.026 bln

    7:05 a.m. May 7, 2020

    - Ciara Linnane

  10. Bristol Myers Q1 adj. EPS $1.72; FactSet consensus $1.49

    7:05 a.m. May 7, 2020

    - Ciara Linnane

  11. Bristol Myers Q1 loss per share 34 cents vs. EPS $1.04

    7:05 a.m. May 7, 2020

    - Ciara Linnane

  12. Activision Blizzard’s Play for a Pandemic Premium

    8:54 p.m. May 1, 2020

    - Connor Smith

  13. Syndax Pharmaceuticals Gains 57% After Cancer Conference

    12:57 p.m. April 28, 2020

    - Bill Alpert

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bmy

Other News on BMY

  1. IPO Update: Pliant Therapeutics Readies U.S. IPO

    1:39 p.m. May 27, 2020

    - Seeking Alpha

  2. Gotham Asset Management Trims Apple, Bristol-Meyers

    8:45 a.m. May 27, 2020

    - GuruFocus.com

  3. Repare Therapeutics inks multi-target discovery deal with BMY

    6:48 a.m. May 27, 2020

    - Seeking Alpha

  4. Agenus 1181 Is A Potential Cancer Game Changer

    6:38 a.m. May 27, 2020

    - Seeking Alpha

  5. My Perennial Income Portfolio

    3:27 p.m. May 25, 2020

    - Seeking Alpha

  6. Regulatory Deep Dive On The Celgene CVR

    3:54 p.m. May 22, 2020

    - Seeking Alpha

  7. 1 Sale And 10 Buys I Just Made In My Retirement Portfolio

    6:03 p.m. May 21, 2020

    - Seeking Alpha

  8. Nektar Seeing Modest Covid-19 Delays Ahead Of Key Trial Data

    5:23 p.m. May 21, 2020

    - Seeking Alpha

  9. Clovis Oncology Needs a Savior

    12:24 p.m. May 21, 2020

    - GuruFocus.com

  10. Loading more headlines...
/news/pressrelease/company/us/bmy

Press Releases on BMY

  1. Chemotherapy Drugs Market to Witness a Pronounce Growth During 2023

    9:53 a.m. May 27, 2020

    - Market Insight Reports

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.